Asia Pharmaceutical Group is located in Jinan, the capital of Shandong Province, a comprehensive group company integrating production, sales, and R&D. The group has six subsidiaries, including Jinan Asia Pharmaceutical Co., Ltd., Jinan Hualing Pharmaceutical Co., Ltd., Jinan Hualing Trading Co., Ltd., HL-PHARMA USA CORPORATION, and Asia Pharmaceutical Natural Nutrition Food Branch. Since 1989, the company has focused on the production and R&D of choline and betaine series products as nutritional fortifiers, and is a world-leading manufacturer of food-grade choline and betaine series products.
Among them, the production process development of "choline bitartrate" is a national Spark Program project, and its production process and quality have reached the international advanced level. In 2018, Asia Pharmaceutical Natural Nutrition Food Branch was established, which pioneered the launch of choline series nutritional and health food in China, providing high-quality choline nutritional supplements for global consumers and customers with a more professional team and technology.
1989
年
Commencing Choline Chloride manufacturing in 1989
Jinan Hualing Pharmaceutical Co., Ltd. was jointly founded with Mitsubishi of Japan in 1995

1993
年
Asia Pharmaceutical Co.,Ltd was established in 1993
The first domestic food-grade choline manufacturer.

2021
年
A natural nutrition food branch company was established in 2021.
Pioneered the launch of choline series nutritional and health food in China.


Started production of choline chloride

Founded Jinan Asia Pharmaceutical Co., Ltd., a pioneer enterprise in food-grade choline in China.

cooperated with mitsubishi(japan), and EstablishedJinan Hualing Pharmaceutical Co., Ltd

Choline bitartrate conditioned was included in the National Spark Program

Successfully developed choline dihydrogen citrate and exported it to Europe and the United States

Built a new factory in Jiyang and obtained GMP certification

Established the overseas branch HL-PHARMA in Los Angeles, USA

Established the Natural Nutrition Branch of Aisa Pharmaceutical and obtained China's first production license for food-grade choline chloride

Took the lead in launching choline series health foods in China when nutrition and health products were launched in the market

Asia Pharmaceutical Industry Comprehensive Nutrition and Health Development Project
1989
1993
1995
2001
2003
2008
2012
2018
2021
2025
Founded in 1993, Jinan Asia Pharmaceutical Co., Ltd. is a Sino-US joint venture and a world-leading manufacturer of food-grade choline and betaine series products. Its main products include food-grade choline chloride, choline bitartrate, choline dihydrogen citrate, betaine, betaine hydrochloride, DMAE bitartrate, etc. Among them, the production technology development of choline bitartrate is a national Spark Program Project. More than 60% of its products are exported. It has subsidiaries and offices in the United States and the United Kingdom respectively, providing high-quality products and services to well-known customers in infant food, pharmaceutical, health product and cosmetic industries.
Jinan Asia Pharmaceutical Co., Ltd. began the production and R&D of health food in 1998. In 2018, the Natural Nutritional Food Branch was established, which pioneered the launch of choline series health foods in China. Its main products include choline series nutritional supplements, Mianerkang sleep-improving series, medicine-food homology series solid drinks, multi-vitamin and mineral series, etc. With a more professional team and technology, we will provide high-quality nutrition and health food for consumers and customers.
Established in 1995 as a joint venture with Mitsubishi Gas Chemical Company, Inc. of Japan, Jinan Hualing Pharmaceutical Co., Ltd. has a registered capital of 17.5 million RMB and is one of the earliest enterprises engaged in the production and sales of feed-grade choline chloride in China. The company’s main products are feed-grade choline chloride and betaine hydrochloride. More than 70% of its products are exported to Japan, the United States, Australia, Brazil, Taiwan region and other countries and regions.
The Group has set up subsidiaries and offices in the United States and the United Kingdom respectively. The overseas team consists of experts with years of experience in the European and American pharmaceutical industry, who are familiar with the operation modes and demands of overseas customers. While responsible for overseas business management, services and new business negotiation, it is committed to introducing advanced new products, technologies and quality standards from Europe and the United States, helping domestic business become more international and standardized, so as to provide faster, more efficient and higher-quality products and services for overseas customers.